Complete Sequence of a KPC-Producing IncN Multidrug-Resistant Plasmid from an Epidemic Escherichia coli Sequence Type 131 Strain in China
Author(s) -
Liang Chen,
Hongyan Hu,
Kalyan D. Chavda,
Shulong Zhao,
Renkun Liu,
Hui Liang,
Wei Zhang,
Xiumei Wang,
Michael R. Jacobs,
Robert A. Bonomo,
Barry N. Kreiswirth
Publication year - 2014
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.02587-13
Subject(s) - biology , plasmid , escherichia coli , microbiology and biotechnology , gene , multiple drug resistance , genetics , nucleic acid sequence , drug resistance , virology
We report here the nucleotide sequence of a novelbla KPC-2 -harboring incompatibility group N (IncN) plasmid, pECN580, from a multidrug-resistantEscherichia coli sequence type 131 (ST131) isolate recovered from Beijing, China. pECN580 harbors β-lactam resistance genesbla KPC-2 ,bla CTX-M-3 , andbla TEM-1 ; aminoglycoside acetyltransferase geneaac (6 ′)-Ib-cr ; quinolone resistance geneqnrS1 ; rifampin resistance genearr-3 ; and trimethoprim resistance genedfrA14 . The emergence of abla KPC-2 -harboring multidrug-resistant plasmid in an epidemicE. coli ST131 clone poses a significant potential threat in community and hospital settings.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom